Yi Lv
- Surgery top 1%
- Molecular Biology top 5%
- Oncology top 2%
- Epidemiology top 2%
- Pulmonary and Respiratory Medicine top 2%
- Topics
- Liver Disease Diagnosis and Treatment (56 papers)Hepatocellular Carcinoma Treatment and Prognosis (42 papers)Esophageal and GI Pathology (39 papers)
- Cited by
- HepatologyCancer ResearchOncology
- Journals
- SHILAP Revista de lepidopterologíaACS NanoGastroenterology
- Partner nations
- ChinaUnited StatesPortugal
In The Last Decade
Yi Lv
387 papers receiving 7.0k citations
Hit Papers
Peers
Comparison fields: 5 of 158
- Surgery 2.0k
- Molecular Biology 1.6k
- Oncology 1.6k
- Epidemiology 1.4k
- Pulmonary and Respiratory Medicine 1.2k
Countries citing papers authored by Yi Lv
This map shows the geographic impact of Yi Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Lv more than expected).
Fields of papers citing papers by Yi Lv
This network shows the impact of papers produced by Yi Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Lv. The network helps show where Yi Lv may publish in the future.
Co-authorship network of co-authors of Yi Lv
This figure shows the co-authorship network connecting the top 25 collaborators of Yi Lv. A scholar is included among the top collaborators of Yi Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Lv. Yi Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 0 | |
| 7 | 5 | |
| 8 | 8 | |
| 9 | 27 | |
| 10 | 9 | |
| 11 | 2 | |
| 12 | 1 | |
| 13 | An Orally-Administered Nanotherapeutics with Carbon Monoxide Supplying for Inflammatory Bowel Disease Therapy by Scavenging Oxidative Stress and Restoring Gut Immune Homeostasisbreakdown → | 88 |
| 14 | 15 | |
| 15 | 4 | |
| 16 | 26 | |
| 17 | 27 | |
| 18 | 5 | |
| 19 | The KN Motif and Ankyrin Repeat Domains 1/CXXC Finger Protein 5 Axis Regulates Epithelial-Mesenchymal Transformation, Metastasis and Apoptosis of Gastric Cancer via Wnt Signaling | 0 |
| 20 | 47 |
About Yi Lv
Yi Lv is a scholar working on Hepatology, Surgery and Oncology, having authored 419 papers that have together received 7.1k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (56 papers), Hepatocellular Carcinoma Treatment and Prognosis (42 papers) and Esophageal and GI Pathology (39 papers). The work is most often cited by research in Hepatology (1.2k citations), Cancer Research (933 citations) and Oncology (1.6k citations). Yi Lv has collaborated with scholars based in China, United States and Portugal. Frequent co-authors include Xu‐Feng Zhang, Rongqian Wu, Zhengwen Liu, Xuemin Liu, Qunying Han, Zheng Wu, Yifan Ren, Jianbin Bi, Jian Dong and Na Li. Their work appears in journals such as SHILAP Revista de lepidopterología, ACS Nano and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.